Amanda F Ghilardi[Author] - Search Results

Year	Number of Results
2016	1
2017	1
2019	2
2021	1
2022	3
2023	2
2024	0

1

Recent advances in the development of RIPK2 modulators for the treatment of inflammatory diseases.

Pham AT, Ghilardi AF, Sun L. Pham AT, et al. Front Pharmacol. 2023 Mar 7;14:1127722. doi: 10.3389/fphar.2023.1127722. eCollection 2023. Front Pharmacol. 2023. PMID: 36959850 Free PMC article. Review.

2

Repurposing Tranexamic Acid as an Anticancer Agent.

Law ME, Davis BJ, Ghilardi AF, Yaaghubi E, Dulloo ZM, Wang M, Guryanova OA, Heldermon CD, Jahn SC, Castellano RK, Law BK. Law ME, et al. Among authors: ghilardi af. Front Pharmacol. 2022 Jan 13;12:792600. doi: 10.3389/fphar.2021.792600. eCollection 2021. Front Pharmacol. 2022. PMID: 35095503 Free PMC article.

3

Anticancer Agents Derived from Cyclic Thiosulfonates: Structure-Reactivity and Structure-Activity Relationships.

Ghilardi AF, Yaaghubi E, Ferreira RB, Law ME, Yang Y, Davis BJ, Schilson CM, Ghiviriga I, Roitberg AE, Law BK, Castellano RK. Ghilardi AF, et al. ChemMedChem. 2022 Jul 19;17(14):e202200165. doi: 10.1002/cmdc.202200165. Epub 2022 May 23. ChemMedChem. 2022. PMID: 35491396 Free PMC article.

4

A novel proteotoxic combination therapy for EGFR+ and HER2+ cancers.

Wang M, Ferreira RB, Law ME, Davis BJ, Yaaghubi E, Ghilardi AF, Sharma A, Avery BA, Rodriguez E, Chiang CW, Narayan S, Heldermon CD, Castellano RK, Law BK. Wang M, et al. Among authors: ghilardi af. Oncogene. 2019 May;38(22):4264-4282. doi: 10.1038/s41388-019-0717-6. Epub 2019 Feb 4. Oncogene. 2019. PMID: 30718919

5

Inhibitors of ERp44, PDIA1, and AGR2 induce disulfide-mediated oligomerization of Death Receptors 4 and 5 and cancer cell death.

Law ME, Yaaghubi E, Ghilardi AF, Davis BJ, Ferreira RB, Koh J, Chen S, DePeter SF, Schilson CM, Chiang CW, Heldermon CD, Nørgaard P, Castellano RK, Law BK. Law ME, et al. Among authors: ghilardi af. Cancer Lett. 2022 May 28;534:215604. doi: 10.1016/j.canlet.2022.215604. Epub 2022 Mar 2. Cancer Lett. 2022. PMID: 35247515

6

Indolyl-chalcone derivatives trigger apoptosis in cisplatin-resistant mesothelioma cells through aberrant tubulin polymerization and deregulation of microtubule-associated proteins.

Steinlein S, Essmann F, Ghilardi AF, Horn H, Schüler J, Hausser A, Sun L, Ott G, Kalla C. Steinlein S, et al. Front Oncol. 2023 May 25;13:1190988. doi: 10.3389/fonc.2023.1190988. eCollection 2023. Front Oncol. 2023. PMID: 37305581 Free PMC article.

7

Disulfide bond-disrupting agents activate the tumor necrosis family-related apoptosis-inducing ligand/death receptor 5 pathway.

Wang M, Law ME, Davis BJ, Yaaghubi E, Ghilardi AF, Ferreira RB, Chiang CW, Guryanova OA, Kopinke D, Heldermon CD, Castellano RK, Law BK. Wang M, et al. Among authors: ghilardi af. Cell Death Discov. 2019 Dec 10;5:153. doi: 10.1038/s41420-019-0228-9. eCollection 2019. Cell Death Discov. 2019. PMID: 31839995 Free PMC article.

8

Gastroprotective effects of hydroethanolic root extract of Arrabidaea brachypoda: Evidences of cytoprotection and isolation of unusual glycosylated polyphenols.

da Rocha CQ, de-Faria FM, Marcourt L, Ebrahimi SN, Kitano BT, Ghilardi AF, Luiz Ferreira A, de Almeida AC, Dunder RJ, Souza-Brito AR, Hamburger M, Vilegas W, Queiroz EF, Wolfender JL. da Rocha CQ, et al. Phytochemistry. 2017 Mar;135:93-105. doi: 10.1016/j.phytochem.2016.12.002. Epub 2016 Dec 21. Phytochemistry. 2017. PMID: 28010885

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year